Immunotherapy with the bispecific antibody MDX-H210 (anti-HER2 × anti-CD64) combined with GM-CSF in HER2 positive hormone resistant prostatic cancer
- 30 September 1999
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 35, S343-S344
- https://doi.org/10.1016/s0959-8049(99)81804-8
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: